M4Q (R2) is a globally harmonized framework for structuring quality information in medicinal product registration ...
How can we tell if a depression treatment works beyond placebo? A new real-world method measuring placebo shows that ...
AI: How does this technological revolution fit with the pharmaceutical regulators who oversee the pharmaceutical sector at ...
Biotech data visualization is often static and fragmented, limiting the ability to see integrated patient journeys and ...
AI is reshaping the life sciences industry in ways that are no longer hypothetical. The question is no longer whether to ...
Since long, drug approvals were defined by months of manual paperwork and red tapes. The regulatory body was often perceived ...
Amendment reduces and simplifies royalty structure on Teverelix ® from ~4% to 2% while preserving global rights and IP control The Company is ...
Data custodians can assume implied consent from patients when sharing personal health information for the primary purpose of providing health care. However, express consent from patients is required ...
UnitedHealth (UNH) and peers face significant margin risk after the CMS's 2027 Medicare Advantage rate proposal fell short of ...
The US Food and Drug Administration (FDA) and the European Medicines Agency (EMA) just issued a joint statement outlining 10 “Guiding Principles” ...
Hims & Hers Health shows 50% revenue growth, $1B in cash, and 2.4x 2026 sales with strong personalization and GLP-1 sales.
Discover how Muhammad Shahid’s bold RDC overhaul transformed supply chain performance across Southeast Asia—eliminating stockouts while slashing carbon emissions by 97%.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results